| Literature DB >> 26729869 |
Olaia A Martínez-Iglesias1, Elvira Alonso-Merino1, Sara Gómez-Rey1, Juan Pedro Velasco-Martín2, Rosa Martín Orozco1, Enrique Luengo1, Rosa García Martín3, Inmaculada Ibáñez de Cáceres4, Agustín F Fernández5, Mario F Fraga6, Pilar González-Peramato7, Constantino Varona8, José Palacios8, Javier Regadera2, Ana Aranda9.
Abstract
Nuclear corepressor 1 (NCoR) associates with nuclear receptors and other transcription factors leading to transcriptional repression. We show here that NCoR depletion enhances cancer cell invasion and increases tumor growth and metastatic potential in nude mice. These changes are related to repressed transcription of genes associated with increased metastasis and poor prognosis in patients. Strikingly, transient NCoR silencing leads to heterochromatinization and stable silencing of the NCoR gene, suggesting that NCoR loss can be propagated, contributing to tumor progression even in the absence of NCoR gene mutations. Down-regulation of the thyroid hormone receptor β1 (TRβ) appears to be associated with cancer onset and progression. We found that expression of TRβ increases NCoR levels and that this induction is essential in mediating inhibition of tumor growth and metastasis by this receptor. Moreover, NCoR is down-regulated in human hepatocarcinomas and in the more aggressive breast cancer tumors, and its expression correlates positively with that of TRβ. These data provide a molecular basis for the anticancer actions of this corepressor and identify NCoR as a potential molecular target for development of novel cancer therapies.Entities:
Keywords: metastasis; nuclear corepressor 1; thyroid hormone receptor; transcription; tumor growth
Mesh:
Substances:
Year: 2016 PMID: 26729869 PMCID: PMC4725484 DOI: 10.1073/pnas.1520469113
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205